T. Robert "Bob" Burke
Co-Chair, UCSF Leadership Council for Global Health
Managing Director (ret.), Metropolitan Real Estate Equity Management
T. Robert Burke is a co-founder of AMB Property Corporation and is currently the Managing Director at Metropolitan Real Estate Equity Management. He was formerly a senior real estate partner with Morrison & Foerster LLP. He is a former member of the Board of Governors of the National Association of Real Estate Investment Trusts and Chairman of the Board of Directors of the Pension Real Estate Association. Burke graduated from Stanford University (1964) and holds a JD degree from Stanford Law School (1967). He is a UCSF Foundation Board member and serves on the Foundation Investment Committee and Foundation Strategic Planning Committee. He was awarded the UCSF Medal in 2003, the university’s highest and most prestigious award, which was given to him for his role as “a real estate leader who assisted in planning and developing the UCSF Mission Bay campus.”
William J. Rutter, PhD
Co-Chair, UCSF Leadership Council for Global Health
Chairman and CEO, Synergenics, LLC
William J. Rutter, PhD is Chairman and CEO of Synergenics, LLC. Dr. Rutter co-founded and acted as chairman of Chiron Corporation, a biotechnology company. In addition, Dr. Rutter has served on boards of several Biotech /Pharmacompanies such as Novartis, Cytokinetics, and Sangamo Biosciences. Dr. Rutter is a senior trustee of the Carnegie Institution of Washington, a member of the National Academy of Sciences and the American Academy of Arts and Sciences. Dr. Rutter has published nearly 400 scientific articles and holds more than 25 patents and patent applications. Previously, Dr. Rutter served as Chairman of the Department of Biochemistry and Biophysics at UCSF and his lab made key contributions to biotechnology and recombinant DNA technology, including the cloning of insulin and the development of a vaccine against Hepatitis B.
Haile T. Debas, MD
Director Emeritus, University of California Global Health Institute
Maurice Galante Distinguished Professor of Surgery, Emeritus
Haile T. Debas, MD is the Director Emeritus of the University of California Global Health Institute and the Founding Executive Director of Global Health Sciences at UCSF, where he has held a variety of leadership positions, including Dean of Medicine, Vice Chancellor for Medical Affairs, and Chancellor. A gastrointestinal surgeon by training, Dr. Debas was chair of the UCSF Department of Surgery and is the Maurice Galante Distinguished Professor of Surgery, Emeritus. A native of Eritrea, he received his MD from McGill University and completed his surgical training at the University of British Columbia. Dr. Debas served as a member of the Committee on Science, Engineering and Public Policy of the National Academy of Sciences and on the Advisory Committee to the Director of the National Institutes of Health. He was the founding Board of Directors chair of the Consortium of Universities for Global Health, and is a current member of the Board of Trustees of the Aga Khan University.
Sir Richard Feachem, KBE, CBE, BSc, PhD , DSc (Med), FREng
Director, Global Health Group at UCSF Institute for Global Health Sciences
Dr. Feachem is the Director of the Global Health Group, an “action tank” in IGHS dedicated to translating research into policy and action. He is Professor of Global Health at both the University of California, San Francisco and the University of California, Berkeley. From 2002 to 2007, Sir Richard served as founding Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria and Under Secretary General of the United Nations. During this time, the Global Fund grew from scratch to become the world’s largest health financing institution for developing countries. Dr. Feachem was formerly the Director for Health, Nutrition and Population at the World Bank, and also served for six years as Dean of the London School of Hygiene and Tropical Medicine. Sir Richard’s contributions have had a significant impact on health worldwide. In recognition of his contributions to global health, Dr. Feachem was knighted by Her Majesty Queen Elizabeth II in 2007.
Nicholas Hellmann, MD
Executive Vice President of Medical and Scientific Affairs, Elizabeth Glaser Pediatric AIDS Foundation
As Executive Vice President of Medical and Scientific Affairs at the Elizabeth Glaser Pediatric AIDS Foundation, Dr. Nicholas Hellmann is responsible for providing strategic direction for the Foundation’s programs and research initiatives, ensuring that children are at the forefront of scientific breakthroughs. Prior to joining the Foundation, Dr. Hellmann played key leadership roles, primarily focused on HIV/AIDS, at the Bill and Melinda Gates Foundation, ViroLogic, Inc., Gilead Sciences, Roche Molecular Systems, and Bristol-Myers Squibb Pharmaceutical Research Institute. He received his MD from the University of Kentucky and served as an assistant professor in the Internal Medicine/Infectious Diseases Division at the University of California, San Francisco.
Sandra R. Hernández, MD
President and CEO of California HealthCare Foundation
Sandra R. Hernández, MD, is the president and chief executive officer of The California Healthcare Foundation. Formerly the CEO of The San Francisco Foundation, she is also assistant clinical professor at the University of California, San Francisco School of Medicine. She maintains an active clinical practice at San Francisco General Hospital in the AIDS clinic. Dr. Hernández is a graduate of Yale University, Tufts University School of Medicine, and the John F. Kennedy School of Government at Harvard University. She has served as the director of public health for the City and County of San Francisco and currently serves on the boards of Blue Shield of California and Lucile Packard Children’s Hospital. She is also a trustee of the Western Asbestos Settlement Trust and serves on the UCSF Advisory Councils of Pediatric Leadership for the Underserved, Clinical and Translational Science Institute, Lesbian Health and Resource Center, and the Program in Medical Education for the Urban Underserved.
Jeffrey (Jeff) Hessekiel
Executive Vice President and General Counsel of Exelixis, Inc.
Jeff Hessekiel is an experienced biopharmaceutical attorney, currently serving as Executive Vice President and General Counsel of Exelixis, Inc. Prior to joining Exelixis, he practiced law at Arnold & Porter FDA and Healthcare group. His clients include a variety of emerging growth and public companies, primarily in the life sciences sector. Prior to joining Arnold & Porter, Mr. Hessekiel held senior legal and operational roles at Gilead Sciences, Inc. At Gilead, he advised on matters ranging from pharmaceutical sales and marketing practices to product distribution, channel management, and government price reporting; he oversaw consolidation of the company's global compliance team, corporate quality managers, and the internal audit group within a risk management framework. At Gilead and in prior law firm positions, Mr. Hessekiel has practiced both litigation and corporate law. Mr. Hessekiel is a director of the Mt. Zion Health Fund and a director of the Sarlo Family Foundation.
Mary Anne Koda-Kimble, PharmD
Dean Emeritus, UCSF School of Pharmacy
Mary Anne Koda-Kimble, PharmD, served as dean of the top-ranked UCSF School of Pharmacy from 1988 to 2012. She brought to the position extraordinary leadership in PharmD education and practice, staunch support for PhD pharmacology education and research, commitment to collaboration across scientific disciplines and a global outlook. Dr. Kimble was a pioneering leader in the movement to train pharmacists as drug therapy scientists. As a result, pharmacists began to work side-by-side with physicians and nurses to provide direct care to patients and expert consultation. She is one of just a few pharmacists elected to the prestigious Institute of Medicine. As an undergraduate, she attended the University of the Pacific in Stockton, California; before earning a degree, she was accepted to the doctor of pharmacy program at UCSF and earned her PharmD.
The Honorable Howard H. Leach
President, Leach Capital, LLC
Howard H. Leach is President of Leach Capital, LLC, in San Francisco, California, as well as Foley Timber & Land Company in Perry, Florida. Leach was United States Ambassador to France from 2001 to 2005. He also served as the Chairman of the Board of Regents of the University of California. He is a graduate of Yale University and attended Stanford Graduate School of Business. Leach has served as director of various companies, including Chairman of Hunter Fan Company in Memphis, Tennessee, and on numerous civic Boards.
Cecilia C. M. Lee
Chairman, David S. L. Lee Foundation
Cecilia C. M. Lee is Chairman of Asian Cultural Teachings, Founder and Honorary Chairman of the Crystal Children’s Choir, and West Valley Community College District of Advancement Foundations. She previously served as a Board Director of KQED (a Bay Area PBS station) and Asian Art Commissioner for the City of San Francisco. Lee also served as a member of the President’s Advisory Committee on the Arts for the John F. Kennedy Center for the Performing Arts, appointed by President George W. Bush. Additionally, she currently serves as an Advisor to the Department of Medicine at the University of California, San Francisco. Lee received her bachelor’s degree from National Taiwan University of Arts.
David S. Lee
Chairman of the Board, eOn Communications Corporation
David S. Lee is Chairman of the Board for eOn Communications Corporation, Cortelco, and the Symbio Group. Lee was a member of the President’s Council on the 21st Century Workforce, appointed by President George W. Bush, and is Regent Emeritus for the University of California. Lee serves as a Senior Advisor to Silver Lake Partners and has also served as Founder for Qume Corporation. He is a member of the Board of Directors for many businesses including Linear Technology Corporation and Daily Wellness Co. He was also an advisor to President Bush and President Clinton through the Advisory Committee on Trade Policy and Negotiation. Born in China, Lee holds an Honorary Doctorate of Engineering and BS degree in Mechanical Engineering from Montana State University and a MS degree in Mechanical Engineering from North Dakota State University.
Sanford R. “Sandy” Robertson
Founder, Francisco Partners
Sandy Robertson is a Founding Partner of Francisco Partners. He was the founder and Chairman of Robertson, Stephens & Company and was also the founder of Robertson, Coleman, Siebel & Weisel, later renamed Montgomery Securities, another prominent technology investment bank. He graduated with a BA and MBA with Distinction from the University of Michigan.
Jaime Sepulveda, MD, MPH, MSc, DrSc
Executive Director, Institute for Global Health Sciences
Haile T. Debas Distinguished Professor
Dr. Jaime Sepulveda is the Executive Director of UCSF Institute for Global Health Sciences, and Professor of Epidemiology, at the University of California, San Francisco. From 2007 to 2011, Dr. Sepulveda was a member of the Foundation Leadership Team at the Bill & Melinda Gates Foundation. He served at the foundation in various roles: as Director of Integrated Health Solutions, Director of Special Initiatives and Senior Fellow in the Global Health Program. Sepulveda worked for more than 20 years in a variety of senior health posts in the Mexican government. After graduating from Harvard University where he obtained his Doctorate, he became Mexico’s Director-General of Epidemiology. At age 36, he was appointed Vice-Minister of Health. From 2003 to 2006, he served as Director of the National Institutes of Health of Mexico. He was for almost a decade Director-General of Mexico’s National Institute of Public Health and Dean of the National School of Public Health.
David (Dave) Smith
Dave Smith is President, Interpacific Group, a private investment firm incorporated in San Francisco in 1986 and linked to General Atlantic, G.A. Bayside Corp. and The Atlantic Philanthropies. Dave has served as longtime advisor to Chuck Feeney. Chuck Feeney is the founding chairman of The Atlantic Philanthropies (AP). The foundation’s four primary giving areas are aging, disadvantaged children and youth, health of populations in developing countries, and reconciliation and human rights. It is a limited life organization with an end date of 2020. Chuck primarily gives through AP. In 2009, he made a $125 million challenge pledge to UCSF Medical Center/Children’s Hospital. He also pledged $125 million to CVRI (Cardiovascular Research Institute) and $20 million to the Helen Diller Family Cancer Research Building. In 2012, he made a gift of $20 million to build a new hub for Global Health Sciences at the UCSF. In all, he has given more than $292 million to UCSF, making him the single-largest contributor to any campus in the UC system.
Holly Smith, MD
Associate Dean Emeritus, UCSF School of Medicine
Joining UCSF as chair of the Department of Medicine in 1964, Lloyd Hollingsworth "Holly" Smith, Jr., MD, built much of the framework that established the University of California, San Francisco as a world-class institution. He has continued to serve the school as professor emeritus. In his twenty-one year tenure (1964-1985) as chair, he created affiliations with the Veterans Affairs Medical Center and San Francisco General Hospital. In addition to his concern for clinical departments, Dr. Smith was a consistent proponent of excellence in the basic sciences. In addition to his campus duties, he was influential in national medical research and educational policy, serving for twenty-two years on the advisory board of the Howard Hughes Medical Institute, as member of the President's Science Advisory Committee during the Nixon administration, and as one of the national study group on General Professional Education of Physicians.
Michael (Mickey) Urdea
Managing Partner, Halteres Associates
Dr. Urdea has devoted his career to human diagnostics. He has been involved in the discovery of new biomarkers, the development of new technologies for biomarker discovery, validation and commercialization, diagnostic test development, manufacturing and marketing, and the management of companies involved in these activities. He serves on the scientific advisory boards and boards of directors of a number of biotechnology, diagnostics, venture capital and philanthropic organizations; he was a member of the Bill and Melinda Gates Foundation Diagnostic Forum. Dr. Urdea is an author on nearly 200 peer-reviewed scientific publications, nearly 300 abstracts and international scientific presentations, and more than 100 issued and pending patents. He received his BS in Biology and Chemistry from Northern Arizona University in Flagstaff and his PhD in Biochemistry from Washington State University in Pullman.
Phyllis Whiteley, PhD
Venture Partner, Wildcat Venture Partners; Co-founder & CEO of Didimi
Dr. Whiteley has more than 25 years of experience spanning academia, biotech industry, business, and portfolio management, and has significant international experience, having established affiliates in Japan and Europe. Her work in Pharmacology, Immunology, and Inflammation has resulted in multiple new chemical entities and publications. While an Executive-in-Residence at Mohr Davidow Ventures, Dr. Whiteley provided hands-on leadership in building and creating multiple companies in diagnostics and personalized medicine including Verinata Health (acquired by Illumina). Dr. Whiteley serves on multiple boards, including The Personalized Medicine Coalition (emeritus) and UCSF T1 Catalyst Program. She received her BA in Chemistry and PhD in Pharmacology from Washington University in St. Louis, Missouri.